O-2372 is an
analgesiccannabinoid derivative created by
Organix Inc. for use in scientific research. It has high affinity for both
CB1 and
CB2receptors, with
Ki values of 1.3 nM at CB1 and 0.57 nM at CB2, but is only moderately soluble in water compared to other related compounds such as
O-2694, which it is a metabolite of.[1]
O-2372 is an
analgesiccannabinoid derivative created by
Organix Inc. for use in scientific research. It has high affinity for both
CB1 and
CB2receptors, with
Ki values of 1.3 nM at CB1 and 0.57 nM at CB2, but is only moderately soluble in water compared to other related compounds such as
O-2694, which it is a metabolite of.[1]